News - Part 14

PRINCETON, NJ – October 14, 2003 – Laureate Pharma L.P. and FeRx, Inc. announce a manufacturing and services agreement for FeRx Incorporated’s MTC-DOX product. Under the contract, Laureate Pharma will provide formulation and filling services to support FeRx’s clinical development programs. Terms of the agreement were not disclosed. “We are delighted to be working with FeRx. There is an excellent fit between FeRx’s technology and Laureate’s capabilities in microparticle manufacturing,”…

PRINCETON, NJ – June 17, 2003 – Laureate Pharma L.P. announces the expansion of its purification capacity with the commissioning of a new automated chromatography system for GMP purification of protein products. The unit is specifically designed for biopharmaceutical purification applications, featuring polymeric, sanitary flowpaths and an array of detectors. In the coming months, the company anticipates installation and validation of an identically configured larger scale chromatography system to purify…

PRINCETON, NJ – May 14, 2003 – Laureate Pharma L.P. announces its recently installed 200-Liter working volume stirred tank bioreactor is now operational and fully validated. Laureate, a privately held contract manufacturing company, offers full services to clients requiring development and production of monoclonal antibody products and other recombinant protein products expressed using mammalian cell culture. Later this year, installation of a 2000-Liter working volume stirred tank bioreactor will be…

PRINCETON, NJ – March 26, 2003 – Laureate Pharma L.P. and TolerRx, Inc. announce a second biopharmaceutical manufacturing and services agreement for TolerRx’s therapeutic monoclonal antibody pipeline. Under the contract, Laureate Pharma will provide purification and aseptic filling services to support TolerRx’s clinical trials. Terms of the agreement were not disclosed. “We are delighted to continue working with TolerRx. There is an excellent fit between TolerRx’s antibody therapeutics and Laureate’s…

Princeton, NJ – January 7, 2003 – Laureate Pharma L.P. today announced the appointment of Lawrence W. Chakrin, Ph.D. as a new member of its Board of Directors. Dr. Chakrin is Corporate Vice President of Science Applications International Corporation (SAIC), the largest employee-owned research and engineering firm in the United States, where he is responsible for corporate development of SAIC’s Biomedical Research Group. Before joining SAIC, Dr. Chakrin was a…

Princeton, NJ – December 5, 2002 – Laureate Pharma L.P. announced the appointment of Stan Zeichner as Director, Sales & Marketing. Reporting to Robert J. Broeze, Ph.D., President, he is responsible for all aspects of sales and marketing for the company. “We are delighted to welcome Stan to our management team,” said Robert J. Broeze, Ph.D., President of Laureate Pharma L.P. “His more than 20 years experience in sales and…

Princeton, NJ – November 4, 2002 – Laureate Pharma L.P. announced the appointment of John J. Morris as Vice President, Controller & Strategic Planning. Reporting to Robert J. Broeze, Ph.D., President, he is responsible for all aspects of finance, supply chain management, information technology, and corporate planning. “It is my privilege to welcome John to our management team”, said Robert J. Broeze, Ph.D., President of Laureate Pharma L.P. “His impressive…

Princeton, NJ, October 17, 2002 /PRNewswire/ – Laureate Pharma L.P. today announced the appointment of F. Peter Boer, Ph.D. as a new member of its Board of Directors. Dr. Boer is President and CEO of Tiger Scientific Inc., a firm providing consulting and investment services in the technology arena. In addition, Dr. Boer is the John J. Lee Adjunct Professor at Yale University, where he teaches environmental engineering in the…

PRINCETON, N.J. and BIRMINGHAM, Ala., Sept. 10, 2002 /PRNewswire/ — Laureate Pharma L.P. and Southern Research Institute announced today the initiation of a strategic collaboration agreement related to developing and manufacturing drug-delivery products using Southern Research’s proprietary microencapsulation process technologies. Under the agreement, Laureate Pharma and Southern Research will collaborate to provide pharmaceutical clients with full microencapsulation services that range from development through commercial scale manufacturing. Terms of the agreement…

PRINCETON, NJ – August 20, 2002 – Laureate Pharma L.P. and TolerRx, Inc. announce the initiation of a biopharmaceutical manufacturing and services agreement for TolerRx’s therapeutic monoclonal antibody pipeline. Under the contract, Laureate Pharma will provide purification and aseptic filling services to support TolerRx’s clinical trials. Terms of the agreement were not disclosed. “We believe there is an excellent fit between our expertise in development and manufacturing of biopharmaceuticals and…